| MELATOX: Evaluation of Percutaneous Dissolvement of Melatonin When Used as Sunscreen; a Randomized, Placebo Controlled, Double-blind Crossover Study on Healthy Volunteers. (NCT02224937) | Zealand University Hospital | 2013-12-01 |
| A Study Investigating the Effect of Food and Esomeprazole on the Single Oral Dose Pharmacokinetics of Alectinib (RO5424802) in Healthy Volunteers. (NCT02023125) | Hoffmann-La Roche | 2013-12-01 |
| Phase 1 Trial of Intravenously Administered Nerofe™ in Subjects With Advanced Malignancies (NCT01690741) | Immune System Key Ltd | 2013-12-01 |
| A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT (NCT02010203) | Heat Biologics | 2013-12-01 |
| A Study of ICT-121 Dendritic Cell Vaccine in Recurrent Glioblastoma (NCT02049489) | Precision Life Sciences Group | 2013-12-01 |
| Phase I Trial of Endocavitary Injection of Bone Marrow Derived CD133+ Cells in Ischemic Refractory Cardiomyopathy (RECARDIO Trial) (NCT02059681) | Centro Cardiologico Monzino | 2013-12-01 |
| Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers Including Absolute Bioavailability and Food Effect (NCT02071121) | Biogen | 2013-12-01 |
| Pharmacokinetic/Pharmacodynamic & Safety Study of G3041 and SEVIKAR® Tablet in Healthy Adult Volunteers (NCT02058472) | Dong-A Pharmaceutical Co., Ltd. | 2013-12-01 |
| Impact of Dopamine Infusion on Insulin Secretion in Healthy Subjects (NCT02053935) | Albert Einstein College of Medicine | 2013-12-01 |
| Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer (NCT01349088) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2013-12-01 |
| A Study of Axiron® in Healthy Participants (NCT02004132) | Eli Lilly and Company | 2013-12-01 |
| Safety Study of a Fluorescent Marker to Visualize Cancer Cells (NCT02097875) | Blaze Bioscience Australia Pty Ltd | 2013-12-01 |
| Evaluation of the Safety and Tolerability of Inhaled Nitric Oxide to Subjects With Cystic Fibrosis (NCT01958944) | Beyond Air Inc. | 2013-12-01 |
| Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant (NCT02038153) | Albert Einstein College of Medicine | 2013-12-01 |
| A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of RO6864018 in Male, Healthy, Asian Participants (NCT02015715) | Hoffmann-La Roche | 2013-12-01 |
| A Bioequivalence Study of ASC-01 Placebo (Aripiprazole 0 mg/Sertraline 100 mg) and Sertraline Tablet in Healthy Male Subjects (NCT02088697) | Otsuka Pharmaceutical Co., Ltd. | 2013-12-01 |
| A Study to Assess the Safety, Pharmacokinetics and Immunogenicity of CR6261 in Japanese Healthy Participants (NCT02016066) | Janssen Pharmaceutical K.K. | 2013-12-01 |
| Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male Subjects (NCT01979380) | Kwang Dong Pharmaceutical co., ltd. | 2013-12-01 |
| Transurethral Myoblast Injection for Urinary Incontinence in Children With Bladder Exstrophy (NCT02075216) | Al-Azhar University | 2013-12-01 |
| Safety, Tolerability and Immunogenicity of a Plant-made H7 Virus-like Particle (VLP) Influenza Vaccine in Adults. (NCT02022163) | Medicago | 2013-12-01 |
| Trial of Afatinib (BIBW 2992) + Cetuximab in Advanced Solid Tumours (NCT02020577) | Boehringer Ingelheim | 2013-12-01 |
| A Study to Evaluate the Effects of JNJ-54861911 on Amyloid Beta Processing in Cerebrospinal Fluid and Plasma in Patients With Prodromal Alzheimer's Disease (NCT01978548) | Janssen Research & Development, LLC | 2013-12-01 |
| A Study of the Effects of Posaconazole on Alectinib (RO5424802) Pharmacokinetics in Healthy Volunteers (NCT01984229) | Hoffmann-La Roche | 2013-12-01 |
| Phase I-II Clinical Trial With Autologous Bone Marrow Derived Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis (NCT02035514) | Germans Trias i Pujol Hospital | 2013-12-01 |
| Single Dose Study to Determine the Safety, Tolerability, and Pharmacokinetic Properties of Lorcaserin Hydrochloride (BELVIQ) in Obese Adolescents From 12 to 17 Years of Age (NCT02022956) | Eisai Inc. | 2013-12-01 |
| Cerebral Oxygenation to Guide Supplemental Oxygen (NCT02017691) | Medical University of Graz | 2013-12-01 |
| A Study of LY2928057 in Hemodialysis Participants (NCT01991483) | Eli Lilly and Company | 2013-12-01 |
| Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease (NCT01977781) | Massachusetts Eye and Ear Infirmary | 2013-12-01 |
| AHN-12 Biodistribution in Advanced Leukemia (NCT01207076) | Masonic Cancer Center, University of Minnesota | 2013-12-01 |
| A Study of LY3108743 in Healthy Participants and Participants With Type 2 Diabetes (NCT01995656) | Eli Lilly and Company | 2013-12-01 |
| A Two-part Single and Multiple Dose Study to Assess the Safety , Pharmacokinetics and Effects of AZD3293 in Healthy Japanese Young and Elderly Volunteers (NCT02005211) | AstraZeneca | 2013-12-01 |
| Effect of Alirocumab on Lipid Metabolism in Adults With Elevated LDL-Cholesterol (NCT01959971) | Sanofi | 2013-12-01 |
| Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults (NCT02030301) | Vical | 2013-12-01 |
| Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors (NCT02013336) | South Plains Oncology Consortium | 2013-12-01 |
| Safety and Tolerability of SOBI002 in Healthy Volunteers Following Single and Repeated Administration (NCT02083666) | Swedish Orphan Biovitrum | 2013-12-01 |
| RCT of Methotrexate Added to Treatment As Usual in Schizophrenia (NCT02074319) | Pakistan Institute of Living and Learning | 2013-12-01 |
| Lung Transplant Subjects Using 19F MRI (NCT02019251) | Hal C Charles | 2013-12-01 |
| Evaluation of the Immediate Effect of Acupuncture on the Upper Trapezius Muscle in Patients With Nonspecific Neck Pain. (NCT01984021) | University of Nove de Julho | 2013-12-01 |
| A Safety and Pharmacokinetics Study of CNTO 3157 in Healthy Japanese and Caucasian Participants (NCT02008279) | Janssen Research & Development, LLC | 2013-12-01 |
| Study of BTK Inhibitor, Ibrutinib in Combination With Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma (NCT01962792) | Pharmacyclics LLC. | 2013-12-01 |
| Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir (NCT01689285) | Radboud University Medical Center | 2013-12-01 |
| Investigation of Potential Drug-drug Interactions Between Faldaprevir and the Immunosuppressant Drugs Cyclosporine or Tacrolimus (NCT02016625) | Boehringer Ingelheim | 2013-12-01 |
| A Study to Investigate the Pharmacokinetics and Safety of Beclomethasone Dipropionate Administered by Breath-Actuated Inhaler and Metered-Dose Inhaler in Healthy Adults (NCT02030457) | Teva Branded Pharmaceutical Products R&D, Inc. | 2013-12-01 |
| A Phase 1 Study of the Pharmacokinetics of RDC5 in Healthy Volunteers (NCT02016742) | Chronos Therapeutics Ltd | 2013-12-01 |
| Absolute Bioavailability of Lu AE58054 in Healthy Subjects (NCT02019394) | H. Lundbeck A/S | 2013-12-01 |
| A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With End Stage Renal Disease and Healthy Subjects (NCT02135276) | Tetraphase Pharmaceuticals, Inc | 2013-12-01 |
| A Study of RO6867461 Administered in Single- and Multiple-Ascending Doses in Patients With Wet Age-Related Macular Degeneration (NCT01941082) | Hoffmann-La Roche | 2013-12-01 |
| Drug-drug Interaction Study(Lobeglitazone, Warfarin) (NCT02002611) | Chong Kun Dang Pharmaceutical | 2013-12-01 |
| Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Are in Remission (NCT01982487) | Roswell Park Cancer Institute | 2013-12-01 |
| Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors (NCT02001623) | Seagen Inc. | 2013-11-30 |
| Relative Bioavailability of Pimasertib in Cancer Patients (NCT01992874) | EMD Serono | 2013-11-30 |
| A Study of Polatuzumab Vedotin in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone in Participants With B-Cell Non-Hodgkin's Lymphoma (NCT01992653) | Genentech, Inc. | 2013-11-29 |
| A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Geriatric and Younger Adult Subjects With Type 1 Diabetes (NCT02003677) | Novo Nordisk A/S | 2013-11-29 |
| MK-8237 (SCH900237) Biomarker Study in Participants With Allergic Rhinitis or Rhinoconjunctivitis (MK-8237-009) (NCT01852825) | Merck Sharp & Dohme LLC | 2013-11-27 |
| Pharmacokinetic Interaction Between SSP-004184 (SPD602) and Midazolam in Healthy Adult Subjects (NCT01989169) | Shire | 2013-11-26 |
| Dose Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2849330 in Subjects With Advanced Her3-Positive Solid Tumors (NCT01966445) | GlaxoSmithKline | 2013-11-26 |
| A Study of LY3009120 in Participants With Advanced Cancer or Cancer That Has Spread to Other Parts of Their Body (NCT02014116) | Eli Lilly and Company | 2013-11-26 |
| Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain Lesions (NCT03603106) | Guerbet | 2013-11-25 |
| Safety, Tolerability, and Immunogenicity of the Human Cytomegalovirus Vaccine (V160) in Healthy Adults (V160-001) (NCT01986010) | Merck Sharp & Dohme LLC | 2013-11-25 |
| Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccine(s) GSK3206641A and GSK3206640A Administered in Adults 18 to 64 Years of Age (NCT01999842) | GlaxoSmithKline | 2013-11-25 |
| Genetically Engineered HSV-1 Phase 1 Study for the Treatment of Recurrent Malignant Glioma (NCT02062827) | University of Alabama at Birmingham | 2013-11-25 |
| Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery (NCT01923506) | City of Hope Medical Center | 2013-11-25 |
| A Study of De-immunized DI-Leu16-IL2 Administered Subcutaneously in Participants With B-cell NHL (NCT01874288) | Alopexx Oncology, LLC | 2013-11-25 |
| Vosaroxin and Azacitidine in Treating Patients With Myelodysplastic Syndromes (NCT01913951) | Washington University School of Medicine | 2013-11-22 |
| A Study of LY03003 in Patients With Early-stage Parkinson's Disease (NCT04044547) | Luye Pharma Group Ltd. | 2013-11-22 |
| Acute Dosing of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-003) (NCT01934647) | Merck Sharp & Dohme LLC | 2013-11-22 |
| A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013) (NCT01953692) | Merck Sharp & Dohme LLC | 2013-11-22 |
| GSK2647544 RD, DDI in Healthy Young and Elderly Volunteers (NCT01978327) | GlaxoSmithKline | 2013-11-22 |
| A Study to Determine the Effect of Multiple Oral Doses and Regimens of KD025 in Healthy Male and Post-menopausal Female Subjects (NCT05918588) | Kadmon, a Sanofi Company | 2013-11-21 |
| Safety and Pharmacokinetics of Regorafenib and Cetuximab in Combination (NCT01973868) | Bayer | 2013-11-21 |
| Study of the Safety and Pharmacokinetics of BGB-283 in Patients With Solid Tumors (NCT02610361) | BeiGene | 2013-11-20 |
| Phase Ib/II Study of Efficacy and Safety of MEK162 and Panitumumab, in Adult mCRC Patients With Mutant or Wild-type RAS Tumors (NCT01927341) | Pfizer | 2013-11-19 |
| Safety and Pharmacokinetics (PK) of a Polyurethane Tenofovir Disoproxil Fumarate (TDF) Vaginal Ring (NCT02006264) | Albert Einstein College of Medicine | 2013-11-19 |
| Study of Safety and Immunogenicity of HIV Vaccines in Healthy Volunteers (NCT01989533) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-11-19 |
| Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms (NCT01862718) | National Institutes of Health Clinical Center (CC) | 2013-11-19 |
| Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults (NCT01993706) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-11-19 |
| CyberKnife Accelerated Hemilarynx Stereotactic Radiotherapy Study for Early-stage Glottic Larynx Cancer (NCT01984502) | University of Texas Southwestern Medical Center | 2013-11-18 |
| A Dose Escalation Study to Assess Safety of GSK2256098 (FAK Inhibitor) in Combination With Trametinib (MEK Inhibitor) in Subjects With Advanced Solid Tumors (NCT01938443) | GlaxoSmithKline | 2013-11-18 |
| Effect of SSP-004184 (SPD602) on the Pharmacokinetics of Simvastatin in Healthy Adult Subjects (NCT01979185) | Shire | 2013-11-18 |
| A Short and Long Intravenous Infusion Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-962212 in Healthy Subjects (NCT03197779) | Bristol-Myers Squibb | 2013-11-18 |
| A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax Combined With Chemotherapy in Participants With B-Cell Non-Hodgkin's Lymphoma (NHL) and DLBCL (NCT02055820) | Hoffmann-La Roche | 2013-11-17 |
| Safety and Efficacy of Resticutis Compared to Platelet-Poor Plasma for Treating Diabetic Foot Ulcers (NCT02989961) | Hanan Jafar | 2013-11-15 |
| A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors (NCT02009449) | Eli Lilly and Company | 2013-11-15 |
| Study to Assess the Safety, Tolerability and Pharmacokinetics (PK) of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-005) (NCT01926509) | Merck Sharp & Dohme LLC | 2013-11-14 |
| ASG-15ME is a Study of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial Cancer (NCT01963052) | Astellas Pharma Global Development, Inc. | 2013-11-14 |
| A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects (NCT01992380) | Avid Radiopharmaceuticals | 2013-11-13 |
| Allogeneic Human Cells (hMSC)in Patients With Idiopathic Pulmonary Fibrosis Via Intravenous Delivery (AETHER) (NCT02013700) | Joshua M Hare | 2013-11-13 |
| Quizartinib With Azacitidine or Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT01892371) | M.D. Anderson Cancer Center | 2013-11-12 |
| AvidinOX + [177Lu]DOTA-biotin (or 177Lu-ST2210) Complex in Patients With Liver Metastases From Colorectal Cancer (NCT02053324) | Alfasigma S.p.A. | 2013-11-11 |
| IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT (NCT01885897) | Masonic Cancer Center, University of Minnesota | 2013-11-11 |
| A Study to Investigate the Recovery, Excretion and Pharmacokinetics of [14C]-GSK2140944 Administered as a Single Intravenous and Single Oral Dose to Healthy Adult Male Subjects (NCT02000765) | GlaxoSmithKline | 2013-11-08 |
| Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation (NCT01634217) | Masonic Cancer Center, University of Minnesota | 2013-11-08 |
| Nanosomal Docetaxel Lipid Suspension in Treating Patients With Advanced Solid Tumors (NCT01957995) | University of Southern California | 2013-11-08 |
| Pilot Study of GVAX in Colorectal Cancer Cells (NCT01952730) | Massachusetts General Hospital | 2013-11-08 |
| A Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound for Unilateral Pallidotomy in the Treatment of Dyskinesia of Parkinson's Disease (NCT02003248) | Yonsei University | 2013-11-08 |
| A Pharmacokinetic Study of Narlaprevir as a Single Dose or With Ritonavir Combination in Patients With Hepatic Impairment and Healthy Matched Volunteers (NCT03832426) | R-Pharm | 2013-11-08 |
| Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma (NCT01983969) | M.D. Anderson Cancer Center | 2013-11-07 |
| Pharmacokinetic Study of Thalidomide in Subjects With Multiple Myeloma (NCT01937442) | Celgene | 2013-11-07 |
| Study of the Safety and Efficacy of MK-8521 Compared to Placebo and a Diabetes Drug in Participants With Type 2 Diabetes Mellitus (MK-8521-003) (NCT01982630) | Merck Sharp & Dohme LLC | 2013-11-07 |
| Phase I Dose Escalation Trial of Volasertib in Combination With Azacitidine in Patients With MDS or CMML (NCT01957644) | Boehringer Ingelheim | 2013-11-06 |